当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析 - 现金流量表

和邦生物

(603077)

  

流通市值:192.52亿  总市值:192.52亿
流通股本:88.31亿   总股本:88.31亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,616,047,432.453,177,564,048.671,634,049,492.447,480,057,304.3
  收到的税费返还88,609,118.7866,091,235.8513,782,527.2337,242,301.96
  收到其他与经营活动有关的现金89,805,300.7259,706,667.8315,728,987.06162,332,673.34
  经营活动现金流入小计4,794,461,851.953,303,361,952.351,663,561,006.737,679,632,279.6
  购买商品、接受劳务支付的现金3,516,002,2542,583,031,345.511,469,592,018.355,829,688,440.22
  支付给职工以及为职工支付的现金485,630,532.41330,340,754.45171,905,988.29884,036,822.91
  支付的各项税费356,560,413.58172,153,568.4858,277,337.98345,101,527.6
  支付其他与经营活动有关的现金126,132,124.5872,366,744.5418,377,070.81152,874,101.7
  经营活动现金流出小计4,484,325,324.573,157,892,412.981,718,152,415.437,211,700,892.43
  经营活动产生的现金流量净额310,136,527.38145,469,539.37-54,591,408.7467,931,387.17
二、投资活动产生的现金流量:
  收回投资收到的现金77,052,422.3977,052,422.39-27,523,493.85
  取得投资收益收到的现金1,853,787.831,120,0001,120,0001,806,347.01
  处置固定资产、无形资产和其他长期资产收回的现金净额942,906.36565,396.01565,396.012,698,447.46
  收到的其他与投资活动有关的现金51,824,133.0140,056,743.0829,165,751.3713,543,230.71
  投资活动现金流入小计131,673,249.59118,794,561.4830,851,147.3845,571,519.03
  购建固定资产、无形资产和其他长期资产支付的现金670,592,812.65469,833,381.35330,976,242.351,116,226,426.99
  投资支付的现金97,066,904.9934,295,953.4826,000,000283,780,066.18
  支付其他与投资活动有关的现金147,724,970.3437,909,960.0311,955,831.432,684,506.63
  投资活动现金流出小计915,384,687.98542,039,294.86368,932,073.751,432,690,999.8
  投资活动产生的现金流量净额-783,711,438.39-423,244,733.38-338,080,926.37-1,387,119,480.77
三、筹资活动产生的现金流量:
  吸收投资收到的现金120,000120,000--
  其中:子公司吸收少数股东投资收到的现金120,000120,000--
  取得借款收到的现金3,443,576,713.762,683,676,713.762,234,676,713.767,981,179,805.55
  收到其他与筹资活动有关的现金74,061,458.4573,931,506.5744,531,637.09159,130,243.5
  筹资活动现金流入小计3,517,758,172.212,757,728,220.332,279,208,350.858,140,310,049.05
  偿还债务支付的现金2,654,844,534.452,093,307,295.781,323,196,478.751,491,322,847.5
  分配股利、利润或偿付利息支付的现金91,599,219.3260,858,628.4230,496,071.9246,664,095.33
  其中:子公司支付给少数股东的股利、利润22,632.74---
  支付其他与筹资活动有关的现金323,420,197.1322,699,727.46320,494,433.531,555,112,829.4
  筹资活动现金流出小计3,069,863,950.872,476,865,651.661,674,186,984.183,293,099,772.23
  筹资活动产生的现金流量净额447,894,221.34280,862,568.67605,021,366.674,847,210,276.82
四、汇率变动对现金及现金等价物的影响-21,786,823.99-7,911,681.591,784,946.918,709,035.49
五、现金及现金等价物净增加额-47,467,513.66-4,824,306.93214,133,978.53,946,731,218.71
  加:期初现金及现金等价物余额6,851,563,060.796,851,563,060.796,851,563,060.792,904,831,842.08
  期末现金及现金等价物余额6,804,095,547.136,846,738,753.867,065,697,039.296,851,563,060.79
补充资料:
  净利润-40,239,432.36--70,744,609.93
  资产减值准备-6,302,681.31-128,021,291.49
  固定资产和投资性房地产折旧-450,354,004.91-920,635,825.49
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-450,354,004.91-920,635,825.49
  无形资产摊销-26,828,454.4-54,748,148.57
  长期待摊费用摊销-196,226.4-5,000,881.64
  处置固定资产、无形资产和其他长期资产的损失--1,237,409.73--1,168,756.89
  固定资产报废损失-41,523.13-131,511.32
  财务费用-54,443,201.89-62,136,404.75
  投资损失--302,393.09-5,670,300.35
  递延所得税--11,319,132.38--69,094,247.39
  其中:递延所得税资产减少--13,606,312.39--74,035,323.03
    递延所得税负债增加-2,287,180.01-4,941,075.64
  存货的减少-338,040,532.42--240,336,248.6
  经营性应收项目的减少-19,921,903.48--53,392,819.13
  经营性应付项目的增加--792,939,171.59--319,993,941.36
  其他---31,826,048.72
  现金的期末余额-6,846,738,753.86-6,851,563,060.79
  减:现金的期初余额-6,851,563,060.79-2,904,831,842.08
  现金及现金等价物的净增加额--4,824,306.93-3,946,731,218.71
公告日期2025-10-292025-08-202025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑